{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpsychiatry-tomorrow.simplecast.com%2Fepisodes%2Fmdma-fda-experts-weigh-in-D9sVHFTK","width":444,"version":"1.0","type":"rich","title":"Will the FDA Approve MDMA-AT?: Experts Weigh In","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/78201557-8217-4bdf-b5e9-8b7e5f52b506/cb4a39fc-9bd2-4828-b3ef-cdaede597805/podcast-episode-art-cab-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/4c3e3e4d-fb55-4e7a-be9e-645586f2fd68\" height=\"200\" width=\"100%\" title=\"Will the FDA Approve MDMA-AT?: Experts Weigh In\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Explore the complex landscape of MDMA-assisted therapy for PTSD as the FDA's decision looms. Expert panelists discuss key challenges, regulatory hurdles, and the future of psychedelic medicine in mental health treatment."}